Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Shares Issued (2020 - 2024)

Historic Shares Issued for Relay Therapeutics (RLAY) over the last 5 years, with Q3 2024 value amounting to $218.2 million.

  • Relay Therapeutics' Shares Issued rose 222127.66% to $218.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $244.3 million, marking a year-over-year decrease of 1683.53%. This contributed to the annual value of $17.9 million for FY2024, which is 4092.41% down from last year.
  • Relay Therapeutics' Shares Issued amounted to $218.2 million in Q3 2024, which was up 222127.66% from $17.9 million recorded in Q1 2024.
  • Relay Therapeutics' 5-year Shares Issued high stood at $427.1 million for Q3 2020, and its period low was -$2.9 million during Q4 2021.
  • In the last 5 years, Relay Therapeutics' Shares Issued had a median value of $902000.0 in 2021 and averaged $63.8 million.
  • As far as peak fluctuations go, Relay Therapeutics' Shares Issued tumbled by 9978.88% in 2021, and later soared by 3146319.29% in 2022.
  • Over the past 5 years, Relay Therapeutics' Shares Issued (Quarter) stood at -$2.5 million in 2020, then dropped by 17.15% to -$2.9 million in 2021, then surged by 59.93% to -$1.2 million in 2022, then surged by 898.64% to $9.4 million in 2023, then soared by 2221.28% to $218.2 million in 2024.
  • Its Shares Issued stands at $218.2 million for Q3 2024, versus $17.9 million for Q1 2024 and $9.4 million for Q3 2023.